Names | |
---|---|
IUPAC name (10αH)-5′α-Benzyl-12′-hydroxy-2′-(propan-2-yl)-9,10-dihydroergotaman-3′,6′,18-trione | |
Systematic IUPAC name (6aR,9R,10aR)-N-oxazolopyrrolopyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindoloquinoline-9-carboxamide | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.037.706 |
IUPHAR/BPS | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C35H41N5O5 |
Molar mass | 611.73 g/mol |
Pharmacology | |
ATC code | C04AE04 (WHO) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
Dihydroergocristine is an ergot alkaloid. Alongside dihydroergocornine and dihydroergocryptine, it is one of the components of ergoloid mesylates.
References
Peripheral vasodilators (C04) | |
---|---|
Phenylethanolamine derivatives | |
Alpha blockers |
|
Nicotinic acid and derivatives | |
Purine derivatives | |
Ergot alkaloids | |
Other peripheral vasodilators |
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |